Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec:244:109180.
doi: 10.1016/j.thromres.2024.109180. Epub 2024 Oct 12.

Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study

Jose Manuel Calvo Villas  1 , Manuel Rodríguez López  2 , Jorge Cuesta Tovar  3 , Santiago Bonanad Boix  4 , Juan Carlos Reverter Calatayud  5 , María Teresa Álvarez-Román  6
Affiliations

Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study

Jose Manuel Calvo Villas et al. Thromb Res. 2024 Dec.
No abstract available

Keywords: Gene therapy; Hemophilia; Management; Resources.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest This study has been promoted by the Spanish Society of Thrombosis and Hemostasis (SETH) and funded by CSL Behring. JMCV has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from Takeda, Bayer, CSL Behring, Novo Nordisk, Sobi, Roche, and Pfizer. MRL has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from CSL Behring, Novo Nordisk, and Sobi. JCT has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from Takeda, Bayer, Sanofi, CSL Behring, Novo Nordisk, Sobi, Roche, and Octapharma. SB has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from Takeda, Bayer, Biomarin, Sanofi, CSL Behring, Novo Nordisk, Sobi, Roche, Octapharma, and Pfizer. JCR has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from Octapharma, Bayer, Sanofi, CSL Behring, Boehringer Ingelheim, Werfen, Stago, Siemens, Rovi, Bristol Myers Squibb, Pfizer, Novo Nordisk, and Roche. MTAR has received honoraria for attending symposia/congresses, speaking and consultancy, and/or research grants from Takeda, Bayer, Biomarin, Sanofi, CSL Behring, Novo Nordisk, Sobi, Roche, Octapharma, and Pfizer.